cardiology
-
CardioOne Secures $8M, Expands Cardiology Enablement Platform into New Markets
CardioOne, a startup built at Redesign Health, partners with independent cardiology practices to help them transition to value-based care. On Monday, the company announced it has raised $8 million in seed funding and has three new partners.
-
Geisinger Launches Heart Failure Monitoring Program Using Bodyport’s Smart Scale
Geisinger is launching a pilot program in partnership with virtual heart failure monitoring startup Bodyport. About 200 of the health system’s heart failure patients will be using Bodyport’s cardiac scale at home — the scale uses sensors to measure a person’s metrics of heart function and body fluid status after they stand on it for about 20 seconds.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
MedCity Influencers, Devices & Diagnostics
To Optimize Health Outcomes, Home Medical Devices Must Operate Within Disease Management Programs
Rich multimedia content, chatbots and human interaction all play important roles in helping new health technologies become part of a patient’s lifestyle.
-
Magenta Medical Rakes In $55M for ‘World’s Smallest Heart Pump’
Israeli medical device developer Magenta Medical recently closed a $55 million financing round. The new funding will be used primarily to help Magenta attain FDA approval for its flagship product — a percutaneous left ventricular assist device called Elevate.
-
MedCity Influencers, Physicians
The Impending Shift in the Delivery of Cardiac Care Creates Opportunities for Physicians and Hospitals
The shifting of services to outpatient settings will likely cause hospitals to unwind their contractual relationships with cardiologists, sending the physicians back into private practice. Astute hospital administrators will have already anticipated the migration of cardiologists away from hospital inpatient care and started to prepare for a different type of alignment with cardiologists.
-
A predictive analytics tool for strokes
Alviss.ai CEO and Founder Dr. Pavel Overtchouk talks about how the company’s stroke prediction software seeks to be the first attempt to apply predictive medicine to cardiovascular interventions and heart surgery.
-
Genetesis rakes in $17.5M as its heart disease test prepares for market entry
Medical imaging company Genetesis recently closed a $17.5 million Series C funding round, bringing its total funding to date to more than $40 million. Most of the funds will go toward clinical trials for the company’s 5-minute test to detect ischemic heart disease, which uses magnetocardiography. Genetesis anticipates the test entering the market in early 2023.
-
iRhythm snags FDA approval for AFib characterization algorithm used in Verily’s wearable
Th FDA granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch. The clearance is for an algorithm that categorizes patients’ AFib by analyzing how much of it they experience over time.
-
Using AI to reduce false alerts for patients with heart monitoring devices to detect cardiac arrhythmias
An infographic illustrates how Medtronic’s AccuRhythm AI suppresses false alerts while maintaining sensitivity.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Judges: Joint winners at INVEST Pitch Perfect’s RPM track address large unmet need, have clear reimbursement path
San Francisco-based Blumio and Saint Paul, Minnesota-based NxGenPort tied for the top prize in the Remote Patient Monitoring and Smart Devices track of INVEST Pitch Perfect, the startup competition integral to MedCity News’ INVEST conference. Here is an in-depth look at each company.
-
ViVE conference highlights commitment to health equity, previews the next chapter of interoperability
The ViVE conference last week was a refreshing collection of discussions exploring how much progress has been made in healthcare transformation and the enormous amount of work yet to be done.
-
Devices & Diagnostics, Health Tech
Apple Watch could be used to detect arrhythmias other than AFib, study shows
A study published in Circulation showed that the Apple Watch’s ECG detected some arrhythmias other than atrial fibrillation. The device is currently cleared to take ECGs and general irregular pulse alerts, which could indicate potential cases of atrial fibrillation.
-
Devices & Diagnostics, Health Tech
Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M
Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash.
-
Devices & Diagnostics, Health Tech
Boston Scientific to acquire cardiac monitoring company Preventice for $925M
Boston Scientific will acquire remote cardiac monitoring company Preventice for $925 million in cash and up to $300 million in milestone payments. The deal is expected to close in mid-2021.
-
Push for better patient outcomes drives new standard of care
In this webinar on Feb. 10,
healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors, represent a new standard of care in remote cardiac monitoring.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
